Inventor · disambiguated record
Lars Linderoth
Also filed as: LINDEROTH LARS
13 granted patents·12 pending applications·185 citations·filing 2010–2021
93Inventor score
Top patents by PatentIndex Score
25 records- 0196US10005827B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2016·Granted Jun 26, 2018·24 cites·43 claims
- 0295US11117947B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2019·Granted Sep 14, 2021·7 cites·23 claims
- 0395US9527900B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2015·Granted Dec 27, 2016·20 cites·51 claims
- 0494US11034746B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2018·Granted Jun 15, 2021·6 cites·40 claims
- 0594US8648041B2Double-acylated GLP-1 derivativesGARIBAY PATRICK WILLIAM·Filed 2010·Granted Feb 11, 2014·31 cites·30 claims
- 0692US9266940B2Double-acylated GLP-1 derivativesWIECZOREK BIRGIT·Filed 2012·Granted Feb 23, 2016·29 cites·50 claims
- 0792US9006178B2Double-acylated GLP-1 derivatives with a linkerKOFOED JACOB·Filed 2011·Granted Apr 14, 2015·23 cites·26 claims
- 0887US10689429B2Double-acylated GLP-1 compoundsNOVO NORDISK AS·Filed 2015·Granted Jun 23, 2020·7 cites·11 claims
- 0987US8815802B2GLP-1 analogues and derivativesKALTHOFF CHRISTOPH·Filed 2010·Granted Aug 26, 2014·19 cites·12 claims
- 1086US9708383B2Double-acylated GLP-1 derivativesMADSEN ALICE RAVN·Filed 2011·Granted Jul 18, 2017·14 cites·16 claims
- 1177US10946074B2GLP-1 derivatives and uses thereofNOVO NORDISK AS·Filed 2017·Granted Mar 16, 2021·2 cites·15 claims
- 1276US9556250B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2013·Granted Jan 31, 2017·2 cites·15 claims
- 1374US10822385B2EGF(A) analogues with fatty acid substituentsNOVO NORDISK AS·Filed 2017·Granted Nov 3, 2020·1 cites·28 claims
- 1471US2023272029A1Co-agonists at glp-1 and gip receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 1571US2022177538A1Co-agonists at glp-1 and gip receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 1664US2018016319A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1762US2017190757A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 1861US2016271263A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1960US2017051034A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2058US2015274801A1Acylated glucagon analoguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2157US2013035285A1Novel glucagon analoguesNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 2257US2016002311A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2357US2020407409A1Egf(a) analogues with fatty acid substituentsCHEN JIANHE·Filed 2020·Application pending·0 cites
- 2457US2013143798A1Novel glucagon analoguesLAU JESPER F·Filed 2011·Application pending·0 cites
- 2547US2015210745A1Double-Acylated GLP-1 Derivatives with a LinkerNOVO NORDISK AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Linderoth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →